期刊
JOURNAL OF IMMUNOLOGY
卷 181, 期 5, 页码 3193-3201出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.181.5.3193
关键词
-
类别
资金
- National Institute of Health [R01 057409, R01 070315]
- Juvenile Diabetes Research Foundation International [1-2006-659]
OX40 is a member of the TNFR superfamily and has potent T cell costimulatory activities. OX40 also inhibits the induction of Foxp(3+) regulatory T cells (Tregs) from T effector cells, but the precise mechanism of such inhibition remains unknown. In the present study, we found that CD4+ T effector cells from OX40 ligand-transgenic (OX4OLtg) mice are highly resistant to TGF-beta mediated induction of Foxp(3+) Tregs, whereas wild-type B6 and OX40 knockout CD4+ T effector cells can be readily converted to Foxp(3+) T cells. We also found that CD4+ T effector cells from OX4OLtg mice are heterogeneous and contain a large population of CD44(high)CD62L(-) memory T cells. Analysis of purified OX4OLtg naive and memory CD4+ T effector cells showed that memory CD4+ T cells not only resist the induction of Foxp(3+) T cells but also actively suppress the conversion of naive CD4+ T effector cells to Foxp(3+) Tregs. This suppression is mediated by the production of IFN-gamma by memory T cells but not by cell-cell contact and also involves the induction of T-bet. Importantly, memory CD4+ T cells have a broad impact on the induction of Foxp(3+) Tregs regardless of their origins and Ag specificities. Our data suggest that one of the mechanisms by which OX40 inhibits the induction of Foxp(3+) Tregs is by inducing memory T cells in vivo. This finding may have important clinical implications in tolerance induction to transplanted tissues.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据